FDA Person
FDAEmily A. Baldwin
View detailed information about Emily A. Baldwin, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 44 inspections of 44 companies, 2023–2026.
Inspections (44)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| September 25, 2026 | Nelia E. Sanchez-Crespo, MD | Not classified | #1338612 | |
| September 1, 2026 | USpharma, Ltd., Co. | Not classified | #1334958 | |
| August 20, 2026 | Pangea Pharmaceuticals, LLC | Not classified | #1332744 | |
| July 31, 2026 | Dong Ki Kim, MD, PhD | Not classified | #1329592 | |
| July 24, 2026 | Seung Hyeok Han, MD, PhD | Not classified | #1330512 | |
| June 3, 2026 | Kimberly P. Cockerham, MD REAL | Not classified | #1322244 | |
| April 10, 2026 | Summit Therapeutics, Inc. | Not classified | #1315522 | |
| February 13, 2026 | Noven Pharmaceuticals Inc | Not classified | #1285900 | |
| January 14, 2026 | Woongchae A. Lee, MD | Not classified | #1298970 | |
| November 7, 2025 | Andrew M. Schneider, MD | VAI | Bioresearch Monitoring: Human Drugs | #1290466 |
| October 17, 2025 | Symbio Research GmbH | Not classified | #1291068 | |
| October 10, 2025 | Eva Kristina Bee | Not classified | #1288330 | |
| July 21, 2025 | Beasley E. Robert, MD | VAI | Product Evaluation: Medical Devices | #1276117 |
| May 21, 2025 | Larkin Community Hospital IRB | Not classified | #1270361 | |
| April 23, 2025 | BPI Labs LLC | VAI | Postmarketing Surveillance and Epidemiology: Human Drugs | #1267652 |
| March 28, 2025 | Victor H. Cambursano, M.D. | NAI | Bioresearch Monitoring | #1266167 |
| March 21, 2025 | Maria Cristina De Salvo, M.D., Ph.D. | Not classified | #1266205 | |
| February 21, 2025 | Alexander J. White, M.D. | Not classified | #1262701 | |
| January 16, 2025 | Idalia Acosta, M.D. | VAI | Bioresearch Monitoring: Human Drugs | #1258521 |
| December 13, 2024 | Carlos Perez, M.D. | VAI | Bioresearch Monitoring: Human Drugs | #1256464 |
Documents (13)
- 483 · Maria Cuesta Torres, M.D. · May 18, 2023
- 483 · BPI Labs LLC · April 23, 2025
- 483 · Tris Pharma Inc. · March 8, 2024
- EIR · Dr. Gretel Trullenque, DO · May 24, 2024
- 483 · Andrew M. Schneider, MD · November 7, 2025
- 483 · Idalia Acosta, M.D. · January 16, 2025
- 483 · Larkin Community Hospital IRB · May 21, 2025
- 483 · Beasley E. Robert, MD · July 21, 2025
- 483 · Orlando L. Rivero, MD · June 8, 2023
- 483 · Nova Southeastern University IRB #1 · August 17, 2023
- 483 · Dr. Bruce G. Rankin, DO · September 22, 2023
- 483 · Luis Pena-Hernandez, M.D. · January 23, 2023
- 483 · Kimberly P. Cockerham, MD REAL · June 3, 2026
Frequently inspected with (10)
Person Information
Name
Emily A. Baldwin
Title
investigator
Role
COMPANY REP
ID: 92d70174-7029-44f4-af30-e3230d4e9507
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.